Metabolic dysfunction-associated fatty liver disease and metabolic-associated steatohepatitis: a review of pathogenesis and potential pharmacological targets

Metabolic dysfunction-associated fatty liver disease and metabolic-associated steatohepatitis: a review of pathogenesis and potential pharmacological targets

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common liver diseases that results from excess fat accumulation in the hepatocytes. The progression of steatosis to hepatocellular necrosis and inflammation leads to metabolic-associated steatohepatitis (MASH...

Full description

Bibliographic Details
Main Authors: Samaneh Olapour, Hamid Yaghooti
Format: Article
Language:fas
Published: Kashan University of Medical Sciences and Health Services 2022-01-01
Series:Fiyz̤
Subjects:
fatty liver disease
steatohepatitis
pathogenesis
drug targets
Online Access:http://feyz.kaums.ac.ir/article-1-4634-en.html

Internet

http://feyz.kaums.ac.ir/article-1-4634-en.html

Similar Items